Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03789786 · ClinicalTrials.gov registry record
Long-term Outcomes of Selective Dorsal Rhizotomy Among Individuals With Cerebral Palsy
A clinical trial, sponsored by Gillette Children's Specialty Healthcare.
- Completed
- Registry status
- 78
- Enrollment target
NCT03789786 is a clinical trial that has completed, run by Gillette Children's Specialty Healthcare. The registered enrollment target is 78 participants.
The verdict
NCT03789786 has completed, sponsored by Gillette Children's Specialty Healthcare.
- COMPLETED
- Registry status
- 78 participants
- Enrollment target
Study Summary
Spasticity affects up to 80% of individuals diagnosed with cerebral palsy. Selective dorsal rhizotomy (SDR) is a surgical method used by some hospitals to permanently reduce spasticity in order to prevent further morbidities. Better understanding of the long-term outcomes of SDR is essential for clinicians and families. The results of this study will have direct clinical impact by equipping providers with the necessary information to counsel families during medical decision making.
Interventions
- BEHAVIORAL Surveys
- DIAGNOSTIC_TEST Gait and Motion Analysis
- DIAGNOSTIC_TEST Gross Motor Function Measure (GMFM)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2018-11-01 |
| Est. Completion | 2020-01-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03789786
The ClinicalTrials.gov registry entry for NCT03789786 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 78 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Gillette Children's Specialty Healthcare, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Surveys is the first listed.
NCT03789786 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03789786 about?
NCT03789786 is a clinical study titled "Long-term Outcomes of Selective Dorsal Rhizotomy Among Individuals With Cerebral Palsy". Spasticity affects up to 80% of individuals diagnosed with cerebral palsy. Selective dorsal rhizotomy (SDR) is a surgical method used by some hospitals to permanently reduce spasticity in order to prevent further morbidities. Better understanding of the long-term outcomes of SDR is essential for cli...
What is the current status of trial NCT03789786?
This trial is currently completed. The enrollment target is 78 participants. The study started on 2018-11-01. Estimated completion is 2020-01-31.
What interventions are being tested in trial NCT03789786?
The interventions under investigation include: Surveys (BEHAVIORAL), Gait and Motion Analysis (DIAGNOSTIC_TEST), Gross Motor Function Measure (GMFM) (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03789786?
This trial is sponsored by Gillette Children's Specialty Healthcare, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.